Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $40.26 $52.54 Friday, 10th May 2024 RARE stock ended at $40.90. This is 0.776% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.23% from a day low at $40.26 to a day high of $41.56.
90 days $40.26 $54.55
52 weeks $31.52 $54.98

Historical Ultragenyx Pharmaceutical Inc. prices

Date Open High Low Close Volume
Jul 26, 2023 $41.44 $42.28 $41.08 $42.14 493 860
Jul 25, 2023 $41.96 $42.22 $41.35 $41.57 431 150
Jul 24, 2023 $43.23 $43.46 $41.60 $42.12 531 612
Jul 21, 2023 $43.49 $43.73 $42.79 $43.20 490 626
Jul 20, 2023 $43.41 $43.58 $42.73 $43.03 406 899
Jul 19, 2023 $44.55 $44.80 $43.10 $43.57 558 782
Jul 18, 2023 $44.22 $44.64 $43.76 $44.21 315 616
Jul 17, 2023 $44.25 $45.72 $44.25 $44.34 309 731
Jul 14, 2023 $44.17 $44.50 $43.66 $44.18 437 867
Jul 13, 2023 $44.21 $44.94 $43.61 $44.17 336 838
Jul 12, 2023 $44.03 $44.03 $43.02 $43.95 445 259
Jul 11, 2023 $44.00 $44.12 $43.12 $43.63 434 005
Jul 10, 2023 $44.26 $45.10 $43.77 $44.15 512 453
Jul 07, 2023 $45.60 $45.80 $44.35 $44.55 403 035
Jul 06, 2023 $45.94 $46.05 $44.86 $45.52 681 092
Jul 05, 2023 $46.58 $46.73 $45.54 $46.43 592 754
Jul 03, 2023 $46.00 $47.08 $45.80 $46.66 253 383
Jun 30, 2023 $46.76 $47.44 $46.10 $46.13 366 496
Jun 29, 2023 $48.02 $48.02 $46.48 $46.65 475 185
Jun 28, 2023 $48.78 $49.14 $47.80 $48.01 412 182
Jun 27, 2023 $48.88 $49.05 $48.13 $48.55 454 341
Jun 26, 2023 $49.98 $49.98 $48.57 $48.62 386 299
Jun 23, 2023 $51.10 $51.37 $48.75 $50.20 1 080 407
Jun 22, 2023 $52.15 $53.32 $51.41 $51.55 884 237
Jun 21, 2023 $50.11 $52.15 $49.56 $52.15 721 038
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT